One Of The Country’s Largest Hospital Organizations to Pay $98.15 Million Settlement on False Claims Act Allegations

by Benesch
Contact

On Monday, August 4, 2014, The Department of Justice announced that Community Health Systems (“CHS”) agreed to pay $98.15 million to settle nine whistleblower lawsuits alleging that the company violated the False Claims Act.  The whistleblowers alleged that CHS knowingly billed Medicare, Medicaid, and TRICARE for medically unnecessary inpatient admissions at 119 hospitals that should have been billed as outpatient or observation services. Additionally, allegations were made that services were rendered to patients at one of CHS’s hospitals in Laredo, Texas in violation of the physician self-referral law, known as the Stark Law.

Tennessee-based CHS is the nation’s largest operator of acute care hospitals. CHS emphasized that under the terms of the agreement, there is no finding of improper conduct by CHS or its affiliated hospitals and that CHS has denied any wrongdoing.

Allegations Concerning Outpatient or Observation Services

According to the whistleblowers’ complaints, CHS routinely admitted Medicare patients from their emergency rooms that did not require admission so that it could bill Medicare at the inpatient rates, rather than the lower outpatient rates. To drive these valuable inpatient admissions, CHS allegedly established daily quotas for Medicare and Medicaid admissions through emergency rooms without regard to medical necessity or patient safety.  CHS supposedly enforced those benchmarks by incentivizing and pressuring emergency department physicians and administrators to meet them. Physicians and administrators who failed to meet CHS’s benchmarks were threatened with termination, and some were allegedly fired.  Among a number of allegations, management at CHS’s Heartland Regional Center in Marion, Illinois purportedly held daily meetings in the emergency room where personnel were required to explain the release of any Medicare or Medicaid patient treated in ER.

The first four complaints were filed by employees working at different CHS hospitals in various capacities: a case management supervisor; a coding specialist; an emergency room physician; and a director of health information management.  Between January 2005 and December 2010, each of them observed the same practices being directed from CHS’s corporate offices and felt the practices they felt violated the federal and/or state False Claims Acts.

Allegations Concerning False Claims at CHS’s Laredo Medical Center

$9 million of the settlement resolves an allegation that Laredo Medical Center (“LMC”), a CHS hospital in Laredo, Texas, improperly billed Medicare for services referred by a physician with a financial interest in the hospital in violation of the Stark law.  Specifically, it was alleged that LMC improperly billed Medicare for services referred by a physician who was offered a medical directorship at LMC, in violation of the Stark Law.  Furthermore, it was also alleged by a coding specialist that LMC presented false claims to the Medicare program for certain cardiac and hemodialysis procedures performed on a higher cost inpatient basis that should have been performed on a lower cost outpatient basis

CIA

Under the settlement, CHS entered into a five-year Corporate Integrity Agreement requiring it to retain independent review organizations to review the accuracy of the claims for inpatient services under federal health care programs, and to engage in significant compliance efforts over the next five years.

CHS Response

CHS and the Justice Department differed on what led up to the alleged misconduct. CHS Chairman and CEO Wayne T. Smith blamed “shifting and ambiguous” regulations on admissions and pushed for the government to “devise sound and reasonable rules for the important decision about whether to admit an individual for inpatient care.”  The Justice Department maintained its allegation of fraud against the company, netting the largest False Claims Act settlement in the U.S. Attorney’s Middle District of Tennessee.

Congressional Hearing by Senate Special Committee on Aging

On July 30, 2014, the Senate Special Committee on Aging held the first Congressional hearing focused on the impact of observation status on patients, just days prior to CHS’s settlement.  Issues discussed included patients who have been held on observation status in a hospital, and their subsequent stay at skilled nursing facility (“SNF”) was not covered by Medicare Part A.  Certain testimonies at the hearing explained that observation care is often indistinguishable from inpatient care as it is difficult for the admitting physician to determine whether the patient is an inpatient or an outpatient when they first see the patient. The two-midnight rule, which took effect October 1, 2013, directs physicians to admit a patient to inpatient status if they anticipate that the patient will remain in the hospital for at least two midnights. However, it is sometimes difficult for a physician to make this determination prior to forming a diagnosis or treatment plan for the patient.

Marna Borgstrom, President and Chief Executive Officer of Yale-New Haven Health System, testified that the two-midnight rule causes confusion and huge bills for patients, strains the doctor-patient relationship, and penalizes hospitals that “provide innovative, efficient care,” especially academic medical centers and safety-net hospitals.  On behalf of the Association of American Medical College’s Council of Teaching Hospitals and Health Systems, she recommended that CMS defer to physicians’ clinical judgment for hospital stays lasting less than two midnights and that Congress eliminate the (statutory) three-day inpatient stay requirement for coverage of care in a SNF.

Notably, despite the HHS Office of Inspector General (“OIG”) expressing its concern about observation status and the need for a careful evaluation of the new two-midnight rule, the OIG’s audit division is conducting an ongoing series of audits (Medicare compliance reviews) at acute care hospitals to determine whether the hospitals are appropriately reimbursed by Medicare. The first area evaluated in the inpatient portion of OIG’s reviews is short inpatient stays, an area that OIG’s work has identified as “at risk for noncompliance.” 

The Centers for Medicare and Medicaid Services (“CMS”) has delayed enforcement of the two-midnight rule through March 2015, at which time hospitals may face financial penalties if auditors determine the hospital could have met the patient's needs in an outpatient setting.  Specifically, CMS will not conduct post-payment patient status reviews for claims with dates of admission from October 1, 2013 through March 31, 2015.  Recovery Auditors will also not conduct pre-payment patient status reviews for claims with dates of admission October 1, 2013 through March 31, 2015. Unaffected by the delay are other types of inpatient reviews by Medicare administrative contractors (“MACs”), recovery audit contractors (“RACs”) and supplemental medical review contractors, such as whether inpatient hospital admissions before October 2013 met the previous admission requirements.  RACs also will continue reviews of less-than two midnight stays.

Conclusion

The allegations against CHS demonstrate that hospitals must carefully consider the distinctions between observation status, outpatient status and inpatient status, especially for Medicare patients who need to continue their recovery in a SNF.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Benesch | Attorney Advertising

Written by:

Benesch
Contact
more
less

Benesch on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.